Fennec Pharmaceuticals Inc. (FENC)
NASDAQ·Healthcare·Biotechnology
$10.56
-4.09%
Mkt Cap $209.10M
Analyst Ratings
No recent rating data.
Price Target (10 analysts)
$16.00
Range $16.00 – $16.00
Implied Upside
+51.5%
Consensus $16.00 vs current $10.56
NASDAQ·Healthcare·Biotechnology
$10.56
-4.09%
Mkt Cap $209.10M
No recent rating data.
Price Target (10 analysts)
$16.00
Range $16.00 – $16.00
+51.5%
Consensus $16.00 vs current $10.56